Table 5.
Postoutbreak Conditional Model Results
| Postoutbreak Conditional Model | Parameter Estimate | Standard Error | 95% Credibility Intervals |
|---|---|---|---|
| Intercept | 2.043 | 0.393 | 1.286, 2.814 |
| Anxiety at Pre-T1 | 0.061 | 0.031 | −0.001, 0.122 |
| Depression at Pre-T1 | 0.608 | 0.030 | 0.549, 0.667 |
| Antidepressant prescription | 0.006 | 0.065 | −0.118, 0.132 |
| Antipsychotic prescription | 0.021 | 0.075 | −0.125, 0.168 |
| Anxiolytic prescription | 0.024 | 0.065 | −0.101, 0.156 |
| Cognition enhancer prescription | 0.003 | 0.077 | −0.150, 0.155 |
| Mood stabilizer prescription | −0.027 | 0.082 | −0.187, 0.130 |
| Diagnosis: anxiety-related | −0.596 | 0.321 | −1.222, 0.028 |
| Diagnosis: bipolar-related | −0.679 | 0.328 | −1.332, −0.039 |
| Diagnosis: depression-related | −0.637 | 0.310 | −1.244, −0.032 |
| Diagnosis: neurocognitive disorder | −0.545 | 0.388 | −1.307, −0.206 |
| Diagnosis: obsessive-compulsive-related | −0.538 | 1.239 | −2.993, 1.911 |
| Diagnosis: psychotic spectrum | −0.584 | 0.323 | −1.21, 0.044 |
| Diagnosis: trauma-related | −0.828 | 0.354 | −1.535, −0.145 |
| Age | −0.004 | 0.003 | −0.009, 0.001 |
| Gender (male/female) | −0.128 | 0.065 | −0.256, 0.001 |
| Hispanic | −0.054 | 0.149 | −0.343, 0.245 |
| Black | −0.137 | 0.132 | −0.394, 0.123 |
| Asian | 0.208 | 0.472 | −0.710, 1.127 |
| Native American | −0.008 | 0.484 | −0.939, 0.955 |
| White | 0.103 | 0.113 | −0.119, 0.326 |
| Slope | −0.008 | 0.139 | −0.274, 0.265 |
| Anxiety at Pre-T1 | 0.014 | 0.012 | −0.009, 0.037 |
| Depression at Pre-T1 | −0.054 | 0.011 | −0.076, −0.033 |
| Antidepressant prescription | −0.009 | 0.024 | −0.055, 0.038 |
| Antipsychotic prescription | −0.056 | 0.028 | −0.109, −0.002 |
| Anxiolytic prescription | 0.015 | 0.023 | −0.032, 0.061 |
| Cognitive enhancer prescription | 0.039 | 0.028 | −0.015, 0.094 |
| Mood stabilizer prescription | −0.03 | 0.029 | −0.088, 0.027 |
| Diagnosis: anxiety-related | 0.192 | 0.113 | −0.026, 0.425 |
| Diagnosis: bipolar-related | 0.245 | 0.116 | 0.013, 0.472 |
| Diagnosis: depression-related | 0.19 | 0.108 | −0.022, 0.399 |
| Diagnosis: neurocognitive disorder | 0.123 | 0.137 | −0.146, 0.385 |
| Diagnosis: obsessive-compulsive-related | 0.196 | 0.606 | −0.927, 1.423 |
| Diagnosis: psychotic spectrum | 0.230 | 0.113 | 0.007, 0.454 |
| Diagnosis: trauma-related | 0.198 | 0.123 | −0.044, 0.441 |
| Age | 0.000 | 0.001 | −0.002, 0.001 |
| Gender (male/female) | −0.003 | 0.024 | −0.048, 0.045 |
| Hispanic | −0.012 | 0.055 | −0.117, 0.097 |
| Black | −0.003 | 0.048 | −0.096, 0.089 |
| Asian | −0.046 | 0.182 | −0.409, 0.322 |
| Native American | 0.078 | 0.197 | −0.325, 0.447 |
| White | −0.039 | 0.041 | −0.121, 0.043 |
| Intercept with slope | −0.079 | 0.014 | −0.107, −0.053 |
| Anxiety at Pre-T1 with depression at Pre-T1 | 0.405 | 0.037 | 0.337, 0.481 |
| Variances | |||
| Var (intercept) | 0.596 | 0.042 | 0.523, 0.687 |
| Var (slope) | 0.043 | 0.006 | 0.031, 0.056 |
Pre-T1, pre–COVID-19 outbreak measurement 1.
Intercept: starting value of anxiety on the first measurement occasion; slope = change in anxiety over time, prescriptions, diagnoses, and race variables are dummy coded, with the reference group being unknown or not available. Gender is dummy coded, with the reference group being female.